The largest database of trusted experimental protocols

Af1433

Manufactured by R&D Systems
Sourced in United States

AF1433 is a laboratory product manufactured by R&D Systems. It is a recombinant human Follistatin-like 1 protein.

Automatically generated - may contain errors

6 protocols using af1433

1

Validating Anti-Osteopontin Antibody Specificity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed to validate the specificity of anti-OPN antibody (AF1433; R&D Systems, Inc., Minneapolis, MN, USA) for subsequent IHC analysis. Protein lysates were prepared in RIPA buffer from a MIBC cell line, 253-J and a NMIBC cell line, RT112. Bradford was used for protein quantification. Proteins were separated by SDS-PAGE prior to transferring onto a PDVF membrane. Blocking was performed for 1 h with 10% milk, prior to overnight incubation in 1:1,000 dilution of AF1433. Secondary antibody was applied for 1 h before visualising using ECL. β-actin (ab8227; Abcam) was used to demonstrate equal protein loading.
+ Open protocol
+ Expand
2

Modulation of Cancer Cell Responses by Stromal Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cancer cells were cultured in a 10-cm dish to 80% confluency. The cells were washed with PBS and then incubated with FBS-free medium. After 48 hours of incubation, the medium was collected, centrifuged (2000 rpm, 10 minutes) and filtered using a 0.2-μm filter to obtain cancer cell conditioned medium (Ca.-CM). The CM was used without additional FBS. CAF-derived cancer [CAF (Ca.)] and TAM-derived cancer media were prepared by adding Ca.-CM to HSCs or M0 macrophages for 48 hours (Figure 1A). Then, the medium was exchanged once, and the supernatant was collected. These supernatants were used as CAF conditioned medium (CAF-CM) and TAM conditioned medium (TAM-CM). CAFs derived from TAM-CM [CAFs (TAM)] and CAF-CM [CAFs (CAF)] were prepared in the same way (Figure 1C). To neutralize OPN in the CM, an OPN antibody (AF1433; R&D Systems, Inc., MN, USA) was added at a concentration of 1.0 μg/mL. In the examination of adding OPN, OPN (1433-OP; R&D Systems, Inc., MN, USA) was added to HSCs at concentrations of 0.1, 0.5 and 1.0 μg/mL, the medium was exchanged once in the same manner as above, and the CM was collected.
+ Open protocol
+ Expand
3

Quantifying Osteogenic Marker Expression in Dental Pulp Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the expression of osteogenic markers, 3×104 passage 5 dental pulp cells were seeded onto 24 mm diameter nanofiber-PDMS scaffolds in 24-well plates (n = 5), and other procedures, such as scaffold sterilization and fixation, were performed as described above.
After fixation and washing three times with 0.01% Tween 20-PBS solution (PBST), 1% Triton X solution was added to each well for 15 min to permeabilize. After washing three times with PBST, 1% bovine serum albumin (BSA) solution was added to each well and incubated at room temperature for 1 h for blocking. Appropriate concentrations of primary antibody (polyclonal anti-human osteopontin goat IgG, R&D Systems AF1433), secondary antibody (anti-goat IgG fluorescein isothiocyanate (FITC)-conjugated, tetramethylrhodamine (TRITC)-conjugated phalloidin), Alexa Fluor® 594 and DAPI solution were continuously added for 1 h, except 5 min for DAPI. Each sample was washed three times with PBST between and after treatment. All scaffolds were mounted on a cover glass after staining was performed and imaged with a high-resolution fluorescence microscope (Nicon N-Storm, Tokyo, Japan).
The intensity of each image was analyzed with the ROI manager tool in ImageJ, randomly selecting five 50,000 pixel-sized square image sites.
+ Open protocol
+ Expand
4

IHC Analysis of CRC Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
FFPE tissue sections were obtained from all CRC patients after tumor resection. Immunohistochemical analysis (IHC) was carried out by standard method. Following antibodies were used: polyclonal rabbit anti-S100A4 (1:1000, PA5-82322, Thermo Fisher Scientific, USA), polyclonal goat anti-SPARC (1:80, AF941, R&D Systems, USA), polyclonal goat anti-SPP1 (1:80, AF1433, R&D Systems, USA). To visualize the antigen-antibody reaction, rabbit anti-goat IgG (1:250, VB2932894, Invitrogen, USA) or poly-HRP anti-mouse/rabbit system (Bond oracle IHC system, TA9145, Leica Biosystems, Germany) were used. The nuclei were counterstained with hematoxylin.
+ Open protocol
+ Expand
5

Enzyme-Linked Immunosorbent Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphate buffered saline (PBS) (Sigma P4417-199TAB), Tris (50 mM, Sigma T6066) buffered saline (150 mM, Fisher Scientific S/3161/65) with Tween-20 (0.01%, Sigma P1379) (TBST) were prepared and used for the study. Microtiter ELISA plates were procured from Costar 9018, Thermo Fisher Scientific whereas the plate reader and RDS-2500 reader were purchased from FLUOstar Omega Microplate Reader (BMG Labtech) and (DETEKT, USA) respectively. Anti-species alkaline phosphatase (A5187 and SAB3700286) was procured from Sigma, USA. The substrate pNPP was procured from BioPanda, USA. The paired antibodies used in the study are summarized in Table 5.

Paired antibody and recombinant protein standard used for the study.

AntibodyRecombinant protein standard
UMODMAB5144; AF5144 (R&D Systems, USA)H00007369-Q01 (Novus Biologicals, USA)
OPNMAB1433; MAB14332R; AF1433 (R&D Systems, USA)1433-OP (R&D Systems, USA)
IL-9MAB2091; AF209; MAB209 (R&D Systems, USA)209-ILB010 (R&D Systems, USA)
+ Open protocol
+ Expand
6

Multicolor Immunofluorescence Staining for CD68, S100A4, SPARC, and SPP1

Check if the same lab product or an alternative is used in the 5 most similar protocols
For IF double staining mouse anti-CD68 monoclonal antibody (1:100, #NBP2-44539, clone KP1, Novus Biologicals); polyclonal rabbit anti-S100A4 (1:1000, PA5-82322, Thermo Fisher Scientific, USA), polyclonal goat anti-SPARC (1:80, AF941, R&D Systems, USA) and polyclonal goat anti-SPP1 (1:80, AF1433, R&D Systems, USA) were used. Combination of secondary antibodies were applied: donkey Cy3-conjugated anti-rabbit antibody (#711-165-152, Dianova, Germany, dilution 1:400), donkey AlexaFluor488-conjugated anti-mouse antibody (#715-545-150, Dianova, Germany, dilution 1:400) and donkey Cy3-conjugated anti-goat antibody (#706-167-003, Dianova, Germany, dilution 1:400). Samples were mounted with Fluoroshield Mounting Medium with DAPI (#ab104135, Abcam, USA) and analyzed by confocal microscopy. Confocal laser scanning microscopy was performed with Carl Zeiss LSM 780 NLO laser scanning spectral confocal microscope (Carl Zeiss, Germany), equipped with 40x objective. Data were acquired and analyzed with Black Zen software (RRID : SCR_018163). All three-color images were acquired using a sequential scan mode.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!